Richard Scott Lemons MD
Professor of Pediatrics, University Utah
Join to View Full Profile
100 N Mario Capecchi DrSalt Lake City, UT 84113
Phone+1 801-662-4700
Fax+1 801-662-4705
Dr. Lemons is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of TennesseeFellowship, Pediatric Hematology/Oncology, 1985
Johns Hopkins UniversityResidency, Pediatrics, 1980 - 1983
George Washington University School of Medicine and Health SciencesClass of 1980
Certifications & Licensure
UT State Medical License 1987 - 2026
MT State Medical License 2017 - 2019
TN State Medical License 1984 - 1990
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Metformin in Children With Relapsed or Refractory Solid Tumors Start of enrollment: 2012 Sep 24
- Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies Start of enrollment: 2013 Jan 01
- PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children Start of enrollment: 2012 Dec 13
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsInvasive procedures and surgery following etranacogene dezaparvovec gene therapy in people with hemophilia B.Niamh O'Connell, Paul van der Valk, Sandra Le Quellec, Esteban Gomez, Paul E Monahan
Journal of Thrombosis and Haemostasis. 2025-01-01 - 3 citationsSafety and Efficacy of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Untreated Patients with Hemophilia B.Richard Lemons, Michael Wang, Julie Curtin, Lynda Mae Lepatan, Christoph Male
TH Open. 2024-01-01 - 1 citationsMapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping Review.Jonathan E Constance, Mary M McFarland, Tallie Casucci, Michael W Deininger, Elena Y Enioutina
JMIR Research Protocols. 2023-05-22
Press Mentions
- Norwalk Schools Aim to Address Inequity, Future Readiness in Five-Year PlanJuly 26th, 2021
Nationwide Cancer Drug Shortage Sparks Fear Among Parents, DoctorsOctober 18th, 2019
Feld Entertainment and Primary Children’s Hospital Announce New Cancer Research Funding EffortOctober 8th, 2015
Grant Support
- Multidiscplinary Basic Cancer Research TrainingNational Cancer Institute1994–1998
- Multidisciplinary Basic Cancer Research TrainingNational Cancer Institute1991–1992
- Retroviral Regulation By The Human Bevi GeneNational Institute Of General Medical Sciences1987
- Retroviral Regulation By The Human Bevi GeneNational Institute Of General Medical Sciences1985–1986
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
